OSI Pharmaceuticals, Inc. (NASDAQ: OSIP)

A class action lawsuit has been commenced on behalf of all persons and entities who purchased or otherwise acquired OSI Pharmaceuticals, Inc. common stock, between October 26, 2004 and November 22, 2004, inclusive (the "Class Period"). The complaint names OSI Pharmaceuticals, Inc., Colin Goddard, Robert I. Ingram, Gabriel Leung, Nicole Onetto,Robert L. Van Nostrand, Michael Atieh, G. Morgan Browne, Edwin A. Gee, Daryl K. Granner, Walter M. Lovenberg, Viren Mehta, Herbert Pinedo, Mark Richmond, John P. White, Merrill, Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. Incorporated, Banc of America Securities LLC, Bear, Stearns & Co. Inc. and Lazard Freres & Co. LLC as Defendants.

Click here to view the complaint.

Click here to view press release.

Click here to join this class action.

Click here to download Adobe Acrobat Reader free of charge.

To find out more about this case, please contact us at shareholderrelations@spornlaw.com or 212-964-0046.

Some Recent Settlements

· In re Harmonic, Inc. Securities Litigation, C-00-2287 (N.D. Cal.)
October 29, 2008 - $15 million cash settlement
(Co-Lead Counsel)

· In re SPX Corp. Securities Litigation, 3:04-CV-99 (W.D.N.C.)
April 13, 2007 - $10 million cash settlement
(Sole Lead Counsel)

· In re PNC Finacial Services Group, Inc. Securities Litigation, 02-CV-271(W.D. Penn.)
April 12, 2007 - $46.675 million recovery
(Co-lead Counsel)

· In re Westar Energy, Inc. Securities Litigation, 03-CV-4003 (D. Kansas)
September 1, 2005 - $30 million cash settlement
(Sole Lead Counsel)

· In re Nicor, Inc. Securities Litigation, 02-CV-5168 (N.D. Ill.)
July 9, 2004 - $39 million cash settlement
(Sole Lead Counsel)